Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: A pilot study

Experimental Hematology

Volumn 24, Issue 12, 1996, Pages 1363-1368

  Bernstein, S H ^a   Christiansen, N P ^a   Fay, J P ^a   Brown, R ^a   Herzig, R ^a   Frankel, S ^a   Blumeson, L ^a   Herzig, G P ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

GM CSF; Priming; Progenitors

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMATOPOIESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LYMPHOMA; MALE; PRIORITY JOURNAL; RASH; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION; URTICARIA;

ADULT; AGED; BONE MARROW TRANSPLANTATION; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HUMANS; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MIDDLE AGED; PILOT PROJECTS; STEM CELLS; TRANSPLANTATION CONDITIONING;

EID: 0029848769     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)